Lv53
1570 积分 2021-02-10 加入
Prognostic value of imaging-based parameters in patients with intermediate-stage hepatocellular carcinoma undergoing transarterial radioembolization
1个月前
已关闭
Radioembolization plus Immune Checkpoint Inhibitor Therapy Compared with Radioembolization plus Tyrosine Kinase Inhibitor Therapy for the Treatment of Hepatocellular Carcinoma
1个月前
已完结
Evolution of Radioembolization in Treatment of Hepatocellular Carcinoma: A Pictorial Review
1个月前
已完结
The Evolving Application of Radiation Segmentectomy for the Treatment of Hepatic Malignancy
1个月前
已完结
Radioembolization for Intermediate-Stage Hepatocellular Carcinoma Maintains Liver Function and Permits Systemic Therapy at Progression
1个月前
已完结
Effect of Previous Transarterial Chemoembolization on Survival and Toxicity after Yttrium-90 Transarterial Radioembolization of Hepatocellular Carcinoma in the Radiation-Emitting SIR-Spheres in Nonresectable Liver Tumor Registry
1个月前
已完结
Early Prediction of Response of Hepatocellular Carcinoma to Yttrium-90 Radiation Segmentectomy Using a Machine Learning MR Imaging Radiomic Approach
1个月前
已完结
Long-term Clinical Outcomes of Yttrium-90 Transarterial Radioembolization for Hepatocellular Carcinoma: A 5-Year Institutional Experience
1个月前
已完结
Boosted-Dose Yttrium-90 Radiation Segmentectomy or Lobectomy for Hepatocellular Carcinoma Refractory to Prior Transarterial Embolization or Chemoembolization: A Single Institution Retrospective Case Series
1个月前
已完结
Benign Biliary Stricture after Yttrium-90 Radioembolization for Hepatocellular Carcinoma
1个月前
已完结
皖公网安备34019202002308
